Drug Information

Drug General Information
Drug ID
D0V9MG
Former ID
DIB014895
Drug Name
KY-382
Indication Atherosclerosis [ICD9: 414.0, 440; ICD10:I70] Investigative [543651]
Company
Kyoto Pharmaceutical Industries Ltd
Target and Pathway
Target(s) Liver carboxylesterase Target Info Modulator [543651]
KEGG Pathway Drug metabolism - other enzymes
Metabolic pathways
Pathway Interaction Database E2F transcription factor network
WikiPathways NRF2 pathway
Nuclear Receptors Meta-Pathway
Heroin metabolism
Irinotecan Pathway
Fluoropyrimidine Activity
Phase I biotransformations, non P450
References
Ref 543651(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2592).
Ref 543651(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2592).

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.